These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 9280630)

  • 1. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
    Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
    Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiepileptic drugs and carnitine].
    Campistol J; Chávez B; Vilaseca MA; Artuch R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S105-9. PubMed ID: 10904975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.
    Tuchman M; Yudkoff M
    Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M; Yakinci C
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children.
    Armutcu F; Ozerol E; Gurel A; Kanter M; Vural H; Yakinci C; Akyol O
    Biol Trace Elem Res; 2004; 102(1-3):1-10. PubMed ID: 15621922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood ammonia levels in epileptic children on 2 dose ranges of valproic acid monotherapy: a cross-sectional study.
    Sharma S; Gulati S; Kabra M; Kalra V; Vasisht S; Gupta YK
    J Child Neurol; 2011 Jan; 26(1):109-12. PubMed ID: 20921570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
    Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
    Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of valproic acid on sleep in children with epilepsy.
    Schmitt B; Martin F; Critelli H; Molinari L; Jenni OG
    Epilepsia; 2009 Aug; 50(8):1860-7. PubMed ID: 19453719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
    Geda G; Caksen H; Içağasioğlu D
    Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine replacement therapy in chronic valproate treatment.
    Melegh B; Kerner J; Acsádi G; Lakatos J; Sándor A
    Neuropediatrics; 1990 Feb; 21(1):40-3. PubMed ID: 2107456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L; Karasik A; Landau Z; Phillip M; Kiviti S; Goldberg-Stern H
    Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid.
    Arslan M; Vurucu S; Balamtekin N; Unay B; Akin R; Kurt I; Ozcan O
    Brain Dev; 2009 Jun; 31(6):405-10. PubMed ID: 18814980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
    Anil M; Helvaci M; Ozbal E; Kalenderer O; Anil AB; Dilek M
    J Child Neurol; 2009 Jan; 24(1):80-6. PubMed ID: 19168820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.